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Trends in Scale and Structure of Korea’s Health Expenditure over 
Last Three Decades (1980-2009): Financing, Functions and 
Providers
This paper introduces statistics related to the size and composition of Korea’s total health 
expenditure. The figures produced were tailored to the OECD’s system of health accounts. 
Korea’s total health expenditure in 2009 was estimated at 73.7 trillion won (US$ 57.7 
billion). The annual per capita health expenditure was equivalent to US$ PPP 1,879. 
Korea’s total health expenditure as a share of gross domestic product was 6.9% in 2009, 
far below the OECD average of 9.5%. Korea’s public financing share of total health 
expenditure increased rapidly from less than 50% before 2000 to 58.2% in 2009. However, 
despite this growth, Korea’s share remained the fourth lowest among OECD countries that 
had an average public share of 71.5%. Inpatient, outpatient, and pharmaceutical care 
accounted for 32.1%, 33.0%, and 23.7% of current health expenditure in 2009, 
respectively. A total of 41.1% of current health expenditure went to hospitals, 28.1% to 
providers of ambulatory healthcare (15.9% on doctor’s clinics), and 17.9% to pharmacies. 
More investment in the translation of national health account data into policy-relevant 
information is suggested for future progress.
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INTRODUCTION
In 2000, the Organisation for Economic Co-operation and Devel-
opment (OECD) published a manual entitled ‘A System of Health 
Accounts’ that set guidelines for the construction of health ac-
counts (1). Health accounts are a systematic description of finan-
cial flows related to healthcare and describe a health system 
from an expenditure perspective. No specific healthcare account-
ing program was in place before the system of health accounts 
(SHA) manual was introduced and implemented in Korea. Sev-
eral Korean researchers developed independent estimates of 
the total health expenditure in Korea (2-8). However, there was 
no point in comparing them with OECD estimates for other 
countries because they included different health expenditure 
items. In 2003, a project involving the construction of Korean 
national health accounts (NHA) was undertaken under the ini-
tiative of the Ministry of Health and Welfare in compliance with 
guidelines set forth in the OECD’s SHA (9). 
  Differences in data on which the estimates are based and in 
the methodology used resulted in significant changes in the val-
ue and structure of total health expenditure between the pre-SHA 
estimates and the SHA estimates. New estimates have made it 
possible to better compare the total health expenditure of Korea 
with that of other OECD countries. Since the first successful 
NHA tables of three dimensions (function, financing, and pro-
vision) were created in 2004, the availability of data sources has 
continuously been checked and new sources added whenever 
available. Awareness and appreciation of the need for and gains 
from the application of SHA to the health expenditure classifi-
cation have steadily increased, with OECD health expenditure 
figures more frequently quoted by health policy makers. 
  This paper aims to introduce figures related to the size and 
composition of Korea’s total health expenditure produced as a 
result of the construction of the Korean NHA tailored to the SHA 
guidelines. Total health expenditure and current health expen-
diture are separately presented; in addition, health expenditures 
per capita and as a share of GDP are shown so that they can be 
compared to those of other OECD countries. An analysis is made 
of how health services are financed, provided, and function.
MATERIALS AND METHODS
Korea’s NHA tables are formulated based on existing statistics 
after a mapping process set forth in detail in Jeong (10). Data 
sources for the public sector include budget and settlement doc-
uments from all government levels, and various statistics from Jeong H-S and Shin J-W  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
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the National Health Insurance (NHI), Industrial Accident Com-
pensation Insurance, and others, as shown in Table 1. Data on 
public health expenditures is quite reliable; however, there are 
limitations on the assessment of the scale and constitution of 
private health expenditures. Appropriate calculations of the 
size of “out-of-pocket excluding cost-sharing” (as named in the 
SHA classification), among sub-headings of “household out-of-
pocket expenditure,” are a key element in the successful con-
struction of the Korean NHA. The cost-sharing portion is de-
rived from the NHI data, where financing, functions, and pro-
viders are clearly and specifically indicated, while “out-of-pock-
et excluding cost-sharing” is calculated by the addition of the 
NHI data as well as data from surveys such as the household 
income and expenditure (HIE) survey, Korean healthcare panel 
study (KoHPS), and survey on NHI out-of-pocket expenditures. 
  The main task is to estimate “out-of-pocket excluding cost-
sharing” by function and by provider with the aid of residual 
techniques. However, the problem is that the total revenues of 
providers are not known exactly. An estimation of the composi-
tion of such provider expenditures is made from other financ-
ing sources, such as the household income and expenditure 
(HIE) survey.
  The HIE survey is conducted monthly in a diary method. The 
heading of “Health and Medical Outlays” (a major classification 
category) includes three subheadings or medium classifica-
tions: “Health and Medical Services,” “Drugs,” and “Medical 
Supplies and Appliances.” “Health and Medical Services” in-
cludes expenditures on outpatient care, inpatient care, dental 
care, traditional medicine, postpartum care, and others, while 
the category of “Drugs” includes prescription drugs, OTC drugs, 
and herbal medicines, and “Medical Supplies and Appliances” 
consists of consumables for health and medical uses, eyeglass-
es, contact lenses, and others. 
  In view of the finding that the number of household mem-
bers noticeably affects health expenditures per household (11), 
health expenditures are totalled by heading and by the number 
of household members and then multiplied by the number of 
households by the number of household members. The surveys 
in which data by number of household members are published 
include: 
1) “Urban household survey of urban and non-farming 
households with 2 persons or more” (Part A in Fig. 1) 
Table 1. Main sources for public and private expenditures
Public expenditures:
General Government other than Social Security: 
   Medical Aid Statistical Yearbook, National Health Insurance Corporation
Social Security: 
   National Health Insurance Statistical Yearbook, National Health Insurance Corporation (2000 and after) and Medical Insurance Statistical Yearbook, National Federation of  
      Medical Insurance (prior to 2000)
   Long Term Care Insurance Statistical Yearbook, National Health Insurance Corporation (2008 and 2009) 
   Yearbook of Industrial Accident Compensation Insurance, Ministry of Labor
Private expenditures:
Private households out-of-pocket:
   Annual report on Household Income and Expenditure Survey, National Statistical Office
   National Health and Nutrition Survey, Ministry of Health and welfare (1989, 1992, 1995, 1998, 2001, 2005, 2007, 2008, 2009)
   Preliminary data set from Korean Healthcare Panel Study (KoHPS), the Korean Institute for Health and Social Affairs (KIHASA), 2010 
   Survey on NHI Out-of-pocket Expenditure, National Health Insurance Corporation (2005-2009) 
   Survey on LTCI Out-of-pocket Expenditure, National Health Insurance Corporation (2010)
   National Health Insurance Statistical Yearbook, National Health Insurance Corporation (2000 and after)
   Medical Insurance Statistical Yearbook, National Federation of Medical Insurance (prior to 2000)
   National Accounts, Korean Bank
   Survey Report on Labor cost of Enterprises, Ministry of Labor
   Survey Report on Establishment Labor Conditions, Ministry of Labor
Private Insurance: 
   Unpublished data, Korea Insurance Development Institute
Other Privates:
   Survey Report on Labor cost of Enterprises, Ministry of Labor
   Survey Report on Establishment Labor Conditions, Ministry of Labor
Fig. 1. Types of household by area and by number of household members.
Households 
with 1 person
Urban 
Households Non-farming 
Households
A C
B Farming 
Households
Non-urban 
Households
Urban 
Households
Non-urban 
Households
Households 
with 2 persons or over
A C
BJeong H-S, et al.  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
http://jkms.org   S15 http://dx.doi.org/10.3346/jkms.2012.27.S.S13
publishes the average monthly health expenditures 
from 1982 onward by number of household members, 
by quarter, and by medium classification.
2) “Household survey of all non-farming households with   
2 persons or more” (A +  A in Fig. 1) publishes average 
monthly health expenditures from 2003 onward by num-
ber of household members, by quarter, and by medium 
classification. 
3) “Household survey of all non-farming households” (A+ 
A + C + C in Fig. 1) publishes the average monthly health 
expenditures from 2006 onward by number of house-
hold members, by quarter, and by medium classifica-
tion. 
  The size of “out-of-pocket expenditures excluding cost-shar-
ing” is obtained by subtracting the “cost-sharing” figure (ob-
tained from administrative statistics such as those of the NHI 
and medical aid program) from the entire household out-of-
pocket expenditures by heading, obtained by adding up expen-
ditures estimated by number of household members on the 
basis of the HIE Survey data. 
  A “mixed approach” is adopted, combining a “bottom-up 
approach,” in which all sub-headings under a particular major 
classification heading together constitute the amount of that 
major classification heading, and a “top-down method,” in 
which the amounts of major classification headings are deter-
mined and then distributed into medium classification and 
again into detailed classification headings. Here is the estima-
tion procedure: 
1) Average monthly amounts by medium classification by 
number of household members are estimated utilizing 
various time series data published in the HIE survey. For 
2006-2009, since the average monthly amounts per an-
num by medium classification by number of household 
members are officially published, those data are utilized 
as they are (A + A + C + C in Fig. 1).
2) The information on “farming households” is not includ-
ed in the previous data. Average monthly health expen-
ditures of “entire households” that include “farming 
households” by medium classification heading are ob-
tained by the following formula:
                (A + A + C + C)T ×
(A + A + B + B)T     
 , 
                                                                (A + A)T
                when T = 2006, 2007, 2008 and 2009
                (A + A + C + C)T+1 ×   
(A + A)T  
×   
(A + A + B + B)T
                                                             (A + A)T+1                 (A + A)T                   ,
                when T = 2005 and before
3) The numbers of households as shown in the population 
and housing census for 1990, 1995, 2000, and 2005 are 
referred to, and, for the years in between, the number of 
households is estimated by interpolation. 
4) A combination of the two preceding sets of data makes  
it possible to estimate the size of the average monthly 
health expenditures that households by number of house-
hold members (1-member household, 2-member house-
hold, 3-member household, etc.) of the entire category 
of households (urban and non-farming households) 
hold for each of the medium classification headings.
5) Annual aggregates of private household out-of-pocket 
expenditures by number of household members are es-
timated by multiplying the preceding monthly expendi-
tures by 12 months since the private household out-of-
pocket expenditures by detailed heading is expressed in 
an annual average of monthly expenditures per house-
hold on the Korean Statistical Information System (KOSIS) 
portal (http://www.kosis.kr/). 
6) Expenditures by both medium and detailed classifica-
tion headings obtained in the foregoing manner are re-
distributed and tailored to the SHA classification. 
RESULTS
Total and current health expenditures 
Total health expenditure (THE) measures the final consump-
tion of health goods and services (current health expenditure 
or CHE) plus capital investment in healthcare infrastructure. It 
has been argued that the two aggregates cannot be directly 
summed up as they refer to different periods of consumption 
where capital formation enables future provisions (12). Korea’s 
THE in 2009 was estimated at 73.7 trillion won, equivalent to 
US$ 57.7 billion (Table 2). Of this, 94.9% was CHE and the remain-
ing 5.1% was expenditures for capital formation by healthcare 
provider institutions. 
  THE in 2009 was 11.2% higher than in 2008 due to an 8.2% 
increase in real health expenditures and the general inflation 
rate (consumer price index) of 2.8% during the year. THE has 
increased annually even though the rate of increase has been on 
a steady decline with annual averages of 19.3% in the 1980s, 14.1% 
in the 1990s, and 12.2% for the period of 2000-2009 (Table 2). In 
Korea, the rate of increase stagnated (2.2%) in 1998 largely due 
to the 1997 Asian financial crisis. This was followed by a rapid 
rate of increase (21.9%) in 2001, largely influenced by reforms 
introduced in the second half of 2000 that mandated the sepa-
ration of drug prescription and dispensing facilities, coupled 
with rises in doctor’s fees (13-15). Subsequent years saw a slight 
drop in the rate of increase (7.5% in 2002 and 9.2% in 2004) due 
to a cost-containment policy, followed by sharp rises again after 
2005, when public benefit coverage was enhanced. Current in-
creases in annual rates have been in the double digits and have 
created a controversy over the future sustainability of the Korean Jeong H-S and Shin J-W  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
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healthcare system. 
  Annual per capita health expenditure was 1.5 million won 
(US$ 1,879) in purchasing power parity and is estimated to have 
increased by 11.7%, or 8.3% in real terms, annually over the last 
decade. Korea’s THE as a share of gross domestic product (GDP) 
was 6.9% in 2009 and is an increase of 0.46 percentage points 
from 2008 level. The increase of 2.7 percentage points during 
one decade (from the figure of 4.3% in 1999) indicates a high 
increase not only in the proportion of overall economic activity 
contributed by health expenditures but also in the burden of 
maintaining the Korean health system. The largest annual in-
crease during the decade came in 2001, when the “THE to GDP” 
ratio grew from 4.5% to 5.1%. That is related to changes in GDP 
as well as changes in health expenditures. Throughout the 1980s, 
THE grew at an annual average rate of 19.3% and was supported 
by average annual GDP increase rates as high as 17.3%. This 
was still the case in the 1990s, when the annual average of THE 
stood at 14.1% and the GDP at 13.2%; however, between 2000 
and 2009 average economic growth slowed to 6.9% despite the 
continued rapid average annual increases as high as 12.2% in 
THE over the same period that resulted in an increase in the 
“THE to GDP” ratio. This ratio increased after the 2008 global 
recession and was further entrenched in 2009; that is, overall 
health spending has been outpacing economic growth.
Financing, functions, and recipients of health expenditures
Table 3 shows the NHA cross-table for functional and financing 
classifications. As a share of THE, public financing accounted 
for 58.2% (government 13.5% and social security 44.7%) and pri-
vate financing for the remainder (private insurance 5.2%, house-
Table 2. Trends in health expenditures 1980-2009
Year
THE  
(nominal) CHE  
(nominal)  
(trillion  
won)
THE (real*)
GDP 
Growth  
rate
THE/GDP THE per capita
Public share 
of THE Size  
(trillion  
won)
Growth  
rate
Size (%)
Growth  
rate
Size  
(thousand 
won)
Growth  
rate 
Size  
(trillion  
won)
Growth  
rate
1980   1.4 34.0%   1.4   5.1 4.1% 22.0% 3.7 9.8% 38 31.9% 21.6%
1981   1.9 29.7%   1.8   5.5 6.9% 26.1% 3.8 2.9% 48 27.7% 21.4%
1982   2.2 15.8%   2.0   5.9 8.0% 14.9% 3.8 0.7% 55 14.0% 24.1%
1983   2.5 14.3%   2.3   6.6 10.5% 17.7% 3.7 -2.8% 62 12.6% 27.3%
1984   2.7   9.1%   2.6   7.0 6.7% 14.8% 3.5 -4.9% 67   7.8% 30.4%
1985   3.1 12.9%   2.9   7.7 10.2% 12.0% 3.6 0.8% 75 11.8% 31.5%
1986   3.4 11.0%   3.2   8.3 8.1% 17.0% 3.4 -5.1% 82   9.9% 30.2%
1987   3.9 14.5%   3.7   9.3 11.1% 17.6% 3.3 -2.7% 94 13.4% 30.6%
1988   4.9 25.2%   4.7 10.8 16.9% 19.2% 3.5 5.1% 116 24.0% 32.8%
1989   6.3 29.0%   6.0 13.2 22.0% 12.9% 4.0 14.3% 148 27.7% 33.6%
1990   7.6 21.3%   7.3 14.8 11.8% 20.7% 4.0 0.6% 178 20.2% 38.4%
1991   8.9 17.1%   8.6 15.8 7.1% 20.9% 3.9 -3.2% 206 15.9% 35.7%
1992 10.8 21.2% 10.3 18.0 14.1% 14.1% 4.1 6.3% 248 20.0% 34.8%
1993 11.9   9.8% 11.3 18.9 4.8% 13.2% 4.0 -3.0% 269   8.7% 35.7%
1994 13.8 15.9% 12.6 20.6 9.1% 17.1% 3.9 -1.1% 309 14.7% 35.0%
1995 15.4 11.5% 14.3 22.0 6.7% 17.1% 3.8 -4.8% 341 10.4% 38.5%
1996 18.1 17.6% 16.8 24.7 12.1% 12.5% 3.9 4.5% 397 16.5% 41.7%
1997 19.9   9.9% 18.5 25.9 5.2% 9.8% 3.9 0.0% 432   8.9% 44.4%
1998 20.3   2.2% 19.1 24.7 -4.9% -1.0% 4.1 3.3% 439   1.5% 49.0%
1999 23.4 15.3% 21.9 28.2 14.4% 9.6% 4.3 5.2% 502 14.5% 50.2%
2000 27.0 15.5% 25.6 31.9 12.9% 9.9% 4.5 5.1% 575 14.5% 48.6%
2001 32.9 21.9% 31.1 37.3 17.1% 8.0% 5.1 12.8% 696 21.0% 54.9%
2002 35.4   7.5% 33.3 39.0 4.6% 10.6% 4.9 -2.8% 744   6.9% 53.7%
2003 39.7 12.2% 37.5 42.3 8.4% 6.5% 5.2 5.4% 830 11.7% 52.4%
2004 43.4   9.2% 41.1 44.6 5.5% 7.8% 5.3 1.3% 904   8.8% 52.6%
2005 49.0 12.9% 46.4 49.0 9.9% 4.6% 5.7 7.9% 1,018 12.7% 52.9%
2006 55.0 12.1% 51.9 53.8 9.7% 5.0% 6.0 6.8% 1,138 11.8% 55.3%
2007 61.4 11.8% 57.7 58.6 9.0% 7.3% 6.3 4.2% 1,268 11.4% 55.8%
2008 66.3   7.9% 62.3 60.4 3.1% 5.3% 6.5 2.5% 1,364   7.5% 55.9%
2009 73.7 11.2% 70.0 65.3 8.2% 3.8% 6.9 7.2% 1,512 10.9% 58.2%
Annual Average Growth Rate
1980s 19.3% 19.5% 10.3% 17.3% 1.6% 17.8%   5.8%
1990s 14.1% 13.8%   7.9% 13.2% 0.7% 13.0%   4.1%
2000s 12.2% 12.3%   8.8%   6.9% 5.0% 11.7%   1.5%
*Base year for THE in real terms is 2005. THE, Total Health Expenditure; CHE, Current Health Expenditure.Jeong H-S, et al.  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
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hold out-of-pocket 32.4%, and others 4.2%). For CHE, the public 
share reached 59.5%, and the private share stood at 40.5%. The 
social security fund (most of which comes from the national 
health insurance program) is the major source of funding for 
healthcare providers; in addition, direct household payments 
play a significant role as well. In this situation, patients have to 
pay high co-payments for their medical bills as well as pay the 
full cost of services that are not included under national health 
insurance benefits. Although spending by private insurance has 
recently increased, its share has remained relatively low.
  The public share of THE barely exceeded 20% in the early 
1980s (Table 2); however, in 1984 it was over 30% due to the ex-
pansion of insurance beneficiaries and it increased to 35% (or 
higher) in 1990 when universal coverage of health insurance 
was implemented. The public share increased to 50% in 1999 
with the implementation of the insurance benefit expansion 
policy in the mid-1990s. The share of public financing also in-
creased rapidly in 2001, when the financial effects of reforms 
that mandated the separation of drug prescription and dispens-
ing facilities started to manifest themselves, reaching a level of 
54.9% (16). After a slight decline in 2002 to 53.7% and in 2003 to 
52.4% due to the cost-containment policy, the share started to 
rise again gradually 58.2% in 2009.
  Fig. 2 shows the allocation of CHE across the different types 
of health services and medical goods (functions). The ratio of 
inpatient to outpatient spending depends on the institutional 
arrangements for healthcare provisions. In 2009, Korean inpa-
tient, outpatient, and pharmaceutical care accounted for 32.1%, 
33.0%, and 23.7% of CHE, respectively. Inpatient share has in-
creased over the last decade, from 29.4% in 2000, while outpa-
tient and pharmaceutical shares have decreased from 35.1% 
and 25.7%, respectively. The outpatient share reached a peak in 
2001 when fees for consultation were increased under the phar-
maceutical reforms (17). The decrease in the pharmaceutical 
share of CHE (despite that sector’s relatively high increase in the 
absolute measure) may be partly explained by the more rapid 
increase of other types of services. The share of CHE allocated 
to public health and prevention activities, such as vaccination 
programs, public health campaigns against alcohol abuse, and 
antismoking initiatives stood at 3.3% in 2009 or around twice its 
share in the early 2000s. This rapid increase is due to a more ac-
tive involvement by the centralized Health Promotion Fund in 
public health and prevention campaigns (18).
  As shown in Fig. 3, 41.1% of CHE went to hospitals in 2009, 
28.1% to providers of ambulatory healthcare (15.9% to doctors’ 
Table 3. Composition of total health expenditure (THE) by financing agent and mode of production, 2009                                                                           Unit: trillion won, (%)
Health expenditure
General  
government
General  
government  
(excl. Social 
security
Social  
security  
funds
Private  
sector
Private  
insurance
Private  
households 
out-of- 
pocket exp.
Others
Total  
expenditure
In-patient services (30.4%) (A) 14.4 (64.4)    3.3 (14.9) 11.1 (49.4)   8.0 (35.6)   2.4 (10.6)   5.6 (25.0) - 22.4 (100)
Out-patient services (31.3%) (B) 11.6 (50.4)  1.6 (6.7) 10.1 (43.6) 11.5 (49.6) 0.8 (3.3) 10.1 (43.9) 0.6 (2.4) 23.1 (100)
Other services (2.7%) (C)   1.6 (80.7)    0.4 (20.4)   1.2 (60.4)   0.4 (19.3) 0.0 (0.9)   0.4 (18.3) 0.0 (0.0)   2.0 (100)
Medical goods dispensed to 
   out-patients (24.0%) (D)
  9.9 (55.9)  1.1 (6.3)   8.8 (49.6)   7.8 (44.1) 0.1 (0.5)   7.7 (43.6) - 17.7 (100)
      Pharmaceutical and other medical 
         non-durables (22.5%)
  9.8 (59.3)  1.1 (6.7)   8.7 (52.6)   6.7 (40.7) 0.1 (0.6)   6.7 (40.1) - 16.6 (100)
Personal Health Expenditure (88.4%) 
   (E = A + B + C + D)
37.6 (57.6)  6.4 (9.8) 31.1 (47.8) 27.6 (42.4) 3.3 (5.0) 23.8 (36.5) 0.6 (0.9) 65.2 (100)
Prevention and public health 
   services (3.1%) (F)
  2.1 (93.9)    1.3 (57.5)   0.8 (36.3) 0.1 (6.1) - 0.1 (4.5) 0.0 (1.6)   2.3 (100)
Health administration 
   and health insurance (3.4%) (G)
  1.9 (76.9)    0.9 (37.5)   1.0 (39.4)   0.6 (23.1)   0.6 (23.1) - -   2.5 (100)
Current Health Expenditure (94.9%) 
   (H = E + F + G)
41.6 (59.5)    8.7 (12.4) 33.0 (47.1) 28.3 (40.5) 3.8 (5.5) 23.9 (34.2) 0.6 (0.9) 70.0 (100)
Capital formation of healthcare 
   provider (5.1%) (I)
  1.3 (33.5)    1.3 (33.5) -   2.5 (66.5) - -   2.5 (66.5)   3.7 (100)
Total Health Expenditure (100%) 
   (J = H + I)
42.9 (58.2)    9.9 (13.5) 33.0 (44.7) 30.8 (41.8) 3.8 (5.2) 23.9 (32.4) 3.1 (4.2) 73.7 (100)
%
  1980  1990  2000  2009
100
80
60
40
20
0
28.0%
34.4%
24.5%
31.8%
23.4%
33.1%
29.4%
25.7%
35.1%
32.1%
23.7%
33.0%
Others
Health administration and 
health insurance
Pharmaceutical and 
other medical non-durables
Outpatient services
Inpatient services
Prevention and public 
health services
Fig. 2. Share of current health expenditure (CHE) by function.Jeong H-S and Shin J-W  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
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clinics), and 17.9% to pharmacies. However, this situation was 
different before the mid-2000 pharmaceutical reform when the 
prescription and dispensing roles of doctors and pharmacists 
were not separated. In 1999, (for example) the pharmaceutical 
share of CHE was as low as 7.0% while the share going to doc-
tors’ clinics was 23.3%. The hospitals’ share has also increased 
over the last decade from 38.3% in 2000 to 41.1% in 2009. 
DISCUSSION
Differences in health spending levels per capita reflect an array 
of market and social factors, as well as diverse financing and or-
ganizational structures of the health systems of the concerned 
countries (19). Korea shows a relatively low (but rapidly grow-
ing) level of health expenditures compared to other OECD coun-
tries. As shown in Fig. 4, Korean health expenditure per capita 
(US$ PPP 1,879) in 2009 was 58.3% of the unweighted OECD 
average (US$ PPP 3,223). The purchasing power parities (PPPs) 
for the whole of GDP are used for the conversion of the expen-
ditures from different national currency units into US dollars. 
Korea also belongs to a group of countries that spend far below 
the OECD average in terms of the “THE to GDP” ratio (6.9% vs 
9.5%). Such trends in this ratio can be ascribed to the combined 
effect of trends in both GDP and health expenditures. For ex-
ample, the gap between the Korean level and the OECD aver-
age was considerably wider in health expenditures (difference 
of 42% in per capita THE) than in economic development (dif-
ference of 20% in per capita GDP).
  Over the past decade, the increase in THE in Korea (12.2%) 
has been higher than the OECD average (8.3%). This can be 
partly explained by the fact that the countries that have experi-
enced the highest increase in health expenditures per capita 
over the last decade are those that ranked relatively low at the 
beginning of the period (19).
  Fig. 4 shows that Korea’s public financing share of THE (58.2%) 
among OECD countries in 2009, remains the fourth lowest, after 
Chile, the United States, and Mexico that have an average pub-
lic share of around 71.5% and is unchanged from 1990. There 
has been a convergence in the levels of the public share of health 
spending among OECD countries over recent decades (19). Korea, 
like many countries with a relatively low public share in the early 
1990s, has increased its public share and reflects health system 
reforms as well as the ongoing expansion of public coverage. 
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  According to Orosz and Morgan (20), the public sector plays 
a dominant role among OECD countries in paying for inpatient 
services even though private financing plays an increasingly 
important role in the area of outpatient services (particularly 
dental care). The public purse covers significantly less of the  
total pharmaceutical expenditures than of expenditures on phy-
sician and hospital services and reflects higher co-payments for 
pharmaceuticals under public insurance schemes in some other 
countries. In this sense, Korea has an unusual public-private   
financing mix of health expenditures by mode of production. 
Korea’s public share in both inpatient and outpatient care is sig-
nificantly lower than the OECD average; however, the public 
share in pharmaceutical expenditures in Korea is as high as the 
OECD average and higher than in the United States and Canada 
where the public share is less than 40%. 
  Until the early 2000s, Korea spent a relatively large share of its 
health expenditures on outpatient care (35.1% of CHE in 2000) 
and a correspondingly lower share on inpatient care (29.4%) com-
pared to most OECD countries (Fig. 2). With the former decreas-
ing and the latter increasing since then, the distribution of CHE 
between outpatient and inpatient care has neared the OECD 
average (24.9% and 36.6%, respectively) (Table 4).
  Variations in pharmaceutical spending are observed in OECD 
countries and reflect the differences in volume, structure of con-
sumption, and pharmaceutical pricing policies. In 2009, Korea’s 
per capita expenditure on pharmaceutical products was US$ 
PPP 423, lower than the OECD average of US$ PPP 488 (Table 4). 
According to the OECD (21), the major pharmaceutical spenders 
were the United States (US$ PPP 956), followed by Canada (US$ 
PPP 744) and Greece (US$ PPP 677); however, Mexico (US$ PPP 
249) and New Zealand (US$ PPP 276) had the lowest per capita 
expenditures on pharmaceuticals. As a share of GDP, Korea’s 
pharmaceutical spending was almost the same as the OECD 
average of 1.6%. Pharmaceutical spending as a share of GDP 
among OECD countries ranged from a group that includes Lux-
embourg, Norway, Denmark and New Zealand (with an aver-
age of less than 1%) to a group that includes Portugal, the Unit-
ed States, Greece, the Slovak Republic and Hungary (with an 
average of more than 2%).
  In conclusion, the figures relating to the size and composi-
tion of Korea’s Total Health Expenditure are introduced and an-
alyzed in this paper. Korea shows a relatively low level of health 
expenditures compared to other OECD countries; however, in-
creases in annual rates have been in the double digits and have 
created a controversy over the future sustainability of the Korean 
healthcare system. The Korean public financing share of health 
expenditures remains among the lowest for OECD countries 
while Korean household out-of-pocket payments are high.
  Sound evidence provided by national health accounts is es-
sential for the equitable and efficient allocation of limited health 
resources in Korea. Linking this evidence with non-monetary 
information (such as output and outcome indicators) can pro-
Table 4. Per capita health expenditure and its composition by financing agent and mode of production, OECD average in US$ PPP, 2009                                 Unit: US$PPP, (%)
Health expenditure
General  
government
General  
government 
(excl. social 
security
Social  
security  
funds
Private  
sector
Private  
insurance
Private 
households 
out-of- 
pocket exp.
Non-profit 
institutions 
and  
Corporations
Rest of  
the  
World
Total  
expenditure
In-patient services (36.6%) (A) 1,057.4  
(86.6) 
531.6  
(43.6) 
525.8  
(43.1) 
163.2  
(13.4) 
49.7  
(4.1) 
105.8  
(8.7) 
7.7  
(0.6) 
- 1,220.6  
(100) 
Out-patient services (24.9%) (B) 572.2  
(68.9) 
255.2  
(30.7) 
317.0  
(38.2) 
257.9  
(31.1) 
48.9  
(5.9) 
201.3  
(24.3) 
7.6  
(0.9) 
- 830.0  
(100) 
Other services (10.4%) (C) 312.1  
(89.7) 
183.9  
(52.9) 
128.2  
(36.8) 
35.9  
(10.3) 
9.6  
(2.8) 
22.0  
(6.3) 
4.3  
(1.2) 
- 348.0  
(100) 
Medical goods dispensed 
   to out-patients (17.7%) (D)
344.2  
(58.3) 
79.6  
(13.5) 
264.6  
(44.8) 
246.4  
(41.7) 
32.2  
(5.5) 
212.5  
(36.0)
1.7  
(0.3)
0.0  
(0.0)
590.6  
(100) 
      Pharmaceutical and 
         other medical non-durables (14.6%)
300.8  
(61.6) 
70.1  
(14.4) 
230.6  
(47.2) 
187.4  
(38.4) 
24.6  
(5.0) 
161.9  
(33.2) 
1.0  
(0.2)
0.0  
(0.0)
488.2  
(100) 
Personal Health Expenditure (89.6%)  
   (E = A + B + C + D)
2,286.0  
(76.5) 
1,050.4  
(35.1) 
1,235.5  
(41.3) 
703.4  
(23.5) 
140.5  
(4.7) 
541.6  
(18.1) 
21.3  
(0.7)
0.0  
(0.0)
2,989.4  
(100) 
Prevention and public health  
   services (3.1%) (F)
85.1  
(81.3) 
64.2  
(61.4) 
20.8  
(19.9) 
19.5  
(18.7) 
0.2  
(0.2) 
1.8  
(1.8) 
17.5  
(16.7) 
0.0  
(0.0)
104.6  
(100)
Health administration and  
   health insurance (3.3%) (G)
76.6  
(70.3) 
33.0  
(30.3) 
43.6  
(40.0) 
32.4  
(29.7) 
24.5  
(22.5) 
4.9  
(4.5) 
2.9  
(2.7) 
0.0  
(0.0)
109.0  
(100) 
Current Health Expenditure (96.0%)  
   (H = E + F + G)
2,447.6  
(76.4) 
1,147.7  
(35.8) 
1,300.0  
(40.6) 
755.3  
(23.6) 
165.2  
(5.2) 
548.3  
(17.1) 
41.8  
(1.3) 
0.1  
(0.0)
3,203.0  
(100) 
Capital formation of healthcare  
   provider institutions (4.0%) (I)
109.9  
(82.8) 
105.8  
(79.7) 
4.2  
(3.1) 
20.4  
(15.4) 
0.1  
(0.1) 
2.3  
(1.8) 
18.0  
(13.6) 
2.3  
(1.8)
132.7  
(100) 
Total Health Expenditure (100%)  
   (J = H+I)
2,557.6  
(76.7) 
1,253.5  
(37.6) 
1,304.1  
(39.1) 
775.7  
(23.3) 
165.2  
(5.0) 
550.7  
(16.5) 
59.8  
(1.8)
2.4  
(0.1)
3,335.7  
(100) 
Data source: OECD (21). 2009: Belgium, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Iceland, Korea, Netherlands, New Zealand, Poland, 
Slovak Republic, Slovenia, Spain, Sweden, and Switzerland. 2008: Australia, Austria, Japan, and Luxembourg. 2007: Norway.Jeong H-S and Shin J-W  •  Scale and Structure of Korea’s Health Expenditure, 1980-2009
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vide the basis for powerful tools to monitor the performance of 
the Korean health system. Among them would be Korea’s health 
outcome compared to other countries with similar incomes 
and health expenditure levels. The next step forward will be to 
translate produced data into policy-relevant information that 
channel resources into priority areas.
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